SCHEMBL8428327

SCHEMBL8428327

COc1ccc2c3c1C(c1cccc(C(F)(F)F)c1)=C2C(C)=C3Cc1nnn[nH]1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 2/20 0.38
NPSR1 Q6W5P4 1/20 0.36
IKBKB O14920 1/20 0.35
AKR1C3 P42330 1/20 0.35
AKR1C2 P52895 1/20 0.35
CTSA P10619 4/20 0.34
MAOA P21397 2/20 0.34
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HSD17B10 Q99714 1/20 0.33
RORC P51449 1/20 0.33
RORB Q92753 1/20 0.33
NR3C1 P04150 1/20 0.33
PGR P06401 1/20 0.33
NR3C2 P08235 1/20 0.33
AR P10275 1/20 0.33
GRIN1 Q05586 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8428371 0.80 MAPT (0.39) NPSR1CTSAKDM4EALDH1A1GAA
SCHEMBL8428247 0.77 KMT2A (0.36) PDE4BALDH1A1HPGDSMN1; SMN2HSD17B10
SCHEMBL8428330 0.69 RXRA (0.48) AKR1C3AKR1C2MAOANR3C1
SCHEMBL8430715 0.67 IKBKB (0.32) IKBKB
SCHEMBL8430781 0.66 IKBKB (0.33) IKBKB
SCHEMBL8428611 0.65
SCHEMBL3786711 0.63 RORB (0.50) PDE4BNPSR1AKR1C3AKR1C2CTSA
SCHEMBL3470072 0.63 PDE4B (0.38) PDE4BCTSASMN1; SMN2MAPT
SCHEMBL13946822 0.63 TYMP (0.40) KDM4EALDH1A1
SCHEMBL12892212 0.62 CA2 (0.58) PDE4BNPSR1KDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5965619-A ADMINISTERING AN INDENE DERIVATIVE OF GIVEN FORMULA, SUCH AS 1-(2,4,6-TRIMETHOXYBENZYLIDENE)-5-DIMETHYLAMINO-2-METHYL-3-INDENYL ACETIC ACID, TO TREAT PRECANCEROUS LESIONS SUCH AS COLONIC ADENOMATOUS POLYPS; SIDE EFFECT REDUCTION CELL PATHWAYS INC. (US) 1999-10-12 US disclosed